Zobrazeno 1 - 10
of 1 282
pro vyhledávání: '"E. Stuber"'
Autor:
Luke R. Smart, Catherine I. Segbefia, Teresa S. Latham, Susan E. Stuber, Kwesi N. Amissah-Arthur, Klenam Dzefi-Tettey, Adam C. Lane, Yvonne A. Dei-Adomakoh, Russell E. Ware
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-14 (2023)
Abstract Background Haemoglobin SC (HbSC) is a common form of sickle cell disease (SCD), especially among individuals of West African ancestry. Persons with HbSC disease suffer from the same clinical complications and reduced quality of life that aff
Externí odkaz:
https://doaj.org/article/b71b43d70ba9457abc2ae35766df103a
Autor:
Emmanuela E Ambrose, Teresa S Latham, Primrose Songoro, Mwesige Charles, Adam C Lane, Susan E Stuber, Abel N Makubi, Russell E Ware, Luke R Smart
Publikováno v:
The Lancet Haematology. 10:e261-e271
Autor:
Luke R. Smart, Emmanuela E. Ambrose, Georgina Balyorugulu, Primrose Songoro, Idd Shabani, Protas Komba, Mwesige Charles, Thad A. Howard, Kathryn E. McElhinney, Sara M. O’Hara, Jodie Odame, Maria Nakafeero, Janet Adams, Susan E. Stuber, Adam Lane, Teresa S. Latham, Abel N. Makubi, Russell E. Ware
Publikováno v:
Acta Haematologica. 146:95-105
Introduction: Stroke is a severe complication of sickle cell anemia (SCA), with devastating sequelae. Transcranial Doppler (TCD) ultrasonography predicts stroke risk, but implementing TCD screening with suitable treatment for primary stroke preventio
Autor:
Peter Olupot-Olupot, George Tomlinson, Thomas N. Williams, Léon Tshilolo, Brígida Santos, Luke R. Smart, Kathryn McElhinney, Thad A. Howard, Banu Aygun, Susan E. Stuber, Adam Lane, Teresa S. Latham, Russell E. Ware
Publikováno v:
Blood.
Realizing Effectiveness Across Continents with Hydroxyurea (REACH, NCT01966731) provides hydroxyurea at maximum tolerated dose (MTD) for children with sickle cell anemia (SCA) in sub-Saharan Africa. Beyond reducing SCA-related clinical events, docume
Autor:
Rosa M. Nieves, Teresa Latham, Nicolle Marte, Luisanna Sanchez, Melissa E. Berges, Gabriela S. Urcuyo, Carla Florencio, Carla Gonzalez, Paola Del Villar, Sheena Chen, Paula Reyes, Daniel Ramirez, Euladys Matos, Manuel Marinez, Susan E. Stuber, William Schultz, Adam Lane, Rafael Mena, Russell E. Ware
Publikováno v:
Blood. 140:451-452
Autor:
Emmanuela E. Ambrose, Teresa Latham, Primrose Songoro, Mwesige Charles, Adam Lane, Susan E. Stuber, Abel Nkono Makubi, Russell E. Ware, Luke R. Smart
Publikováno v:
Blood. 140:447-448
Hydroxyurea reduces the transfusion burden in children with sickle cell anemia: the reach experience
Autor:
Alexandra Power-Hays, George A. Tomlinson, Leon Tshilolo, Brigida Santos, Thomas N. Williams, Peter Olupot-Olupot, Patrick T. McGann, Banu Aygun, Adam Lane, Susan E. Stuber, Teresa Latham, Russell E. Ware
Publikováno v:
American Society of Hematology Annual Scientifc conference
Introduction: Many children with sickle cell anemia (SCA) require blood transfusions, which carry risks and utilize a scarce resource globally, particularly in Africa. Realizing Effectiveness Across Continents with Hydroxyurea (REACH, NCT01966731) ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffae011d2bd52494469c08ea124c95ce
http://hdl.handle.net/10044/1/99893
http://hdl.handle.net/10044/1/99893
Autor:
Maria Nakafeero, Russell E. Ware, Susan E. Stuber, Peter Olupot-Olupot, Patrick T. McGann, George Tomlinson, Léon Tshilolo, Janet Adams, Adam Lane, Brigida Santos, Banu Aygun, Thomas N. Williams, Teresa Latham
Publikováno v:
Blood. 136:17-18
Introduction: Transcranial Doppler (TCD) screening data from Uganda, Tanzania, and Nigeria have documented elevated velocities in >20% of children with sickle cell anemia (SCA) not receiving hydroxyurea treatment. Realizing Effectiveness Across Conti
Autor:
Mwesige Charles, Susan E. Stuber, Adam Lane, Protas Komba, Russell E. Ware, Abel Nkono Makubi, Idd Shabani, Primrose Songoro, Luke R. Smart, Thad A. Howard, Emmanuela E. Ambrose, Teresa Latham
Publikováno v:
Blood. 136:20-21
Introduction: Sickle cell anemia (SCA) is highly prevalent in sub-Saharan Africa with >300,000 annual births, and substantial morbidity and mortality due to limited resources. The burden of stroke in this population is of particular concern, given th
Autor:
Jasmine Baker, Jonathan M. Flanagan, Thomas N. Williams, Brigida Santos, George Tomlinson, Russell E. Ware, Rosa M. Nieves, Adam Lane, Kathryn L McElhinney, Teresa Latham, Susan E. Stuber, Peter Olupot-Olupot, Anu Marahatta, Nicole A. Mortier, William H. Schultz, Angela Rankine-Mullings, Thad A. Howard, Patrick T. McGann, Marvin Reid, Rafael Mena, Banu Aygun, Robert O. Opoka, Léon Tshilolo, Chandy C. John
Publikováno v:
Blood. 136:8-9
Introduction: Hydroxyurea is a potent therapeutic agent for sickle cell anemia (SCA), and treatment at maximum tolerated dose (MTD) is becoming the standard of care. Hydroxyurea exerts its disease-modifying effects primarily through induction of feta